Xiulin Yi

785 total citations
28 papers, 632 citations indexed

About

Xiulin Yi is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xiulin Yi has authored 28 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Xiulin Yi's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects of Natural Compounds (6 papers) and Pancreatic function and diabetes (5 papers). Xiulin Yi is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects of Natural Compounds (6 papers) and Pancreatic function and diabetes (5 papers). Xiulin Yi collaborates with scholars based in China, Macao and United Kingdom. Xiulin Yi's co-authors include Qiu‐Yi Duan, Fu‐Gen Wu, Changxiao Liu, Yazhuo Li, Dexin Kong, Min Gong, Lele Li, Duanyun Si, Zhenghan Di and Cui Tao and has published in prestigious journals such as Journal of the American Chemical Society, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Xiulin Yi

27 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiulin Yi China 12 221 210 123 92 90 28 632
Xiaoye Li China 15 212 1.0× 130 0.6× 53 0.4× 68 0.7× 117 1.3× 102 842
Yinghui Wei China 14 200 0.9× 123 0.6× 45 0.4× 55 0.6× 123 1.4× 26 583
Chien-Tsu Chen Taiwan 13 317 1.4× 135 0.6× 95 0.8× 26 0.3× 117 1.3× 16 813
Xinyan Chen China 16 412 1.9× 71 0.3× 54 0.4× 90 1.0× 91 1.0× 81 999
Siyuan Sun China 17 362 1.6× 155 0.7× 137 1.1× 153 1.7× 49 0.5× 43 988
Kailong Wang China 11 459 2.1× 60 0.3× 115 0.9× 79 0.9× 33 0.4× 21 850
Jiajun Huang China 17 332 1.5× 114 0.5× 67 0.5× 54 0.6× 48 0.5× 47 725
Jian Zheng China 17 343 1.6× 147 0.7× 81 0.7× 180 2.0× 110 1.2× 39 766
Wensheng Zheng China 16 288 1.3× 82 0.4× 76 0.6× 50 0.5× 126 1.4× 35 752

Countries citing papers authored by Xiulin Yi

Since Specialization
Citations

This map shows the geographic impact of Xiulin Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiulin Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiulin Yi more than expected).

Fields of papers citing papers by Xiulin Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiulin Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiulin Yi. The network helps show where Xiulin Yi may publish in the future.

Co-authorship network of co-authors of Xiulin Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiulin Yi. A scholar is included among the top collaborators of Xiulin Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiulin Yi. Xiulin Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhenzhen, Qiaoqiao Han, Cui Tao, et al.. (2025). Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions. Fitoterapia. 187. 106934–106934. 1 indexed citations
2.
Zhang, Miao, Xiaolei Zhou, Zhenzhen Li, et al.. (2025). Decitabine regulates the resistance of HCC to sorafenib through demethylation. Clinical Epigenetics. 17(1). 120–120.
3.
Liu, Sen, Liuyang Zhu, Tianyu Zhao, et al.. (2024). Liver organoids: updates on generation strategies and biomedical applications. Stem Cell Research & Therapy. 15(1). 244–244. 9 indexed citations
4.
Di, Zhenghan, Xiulin Yi, & Lele Li. (2023). Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy. Journal of the American Chemical Society. 145(14). 7931–7940. 32 indexed citations
5.
Yi, Xiulin, Qiu‐Yi Duan, & Fu‐Gen Wu. (2021). Low-Temperature Photothermal Therapy: Strategies and Applications. Research. 2021. 9816594–9816594. 208 indexed citations
6.
Gao, Jing, et al.. (2020). Absorption, tissue disposition, and excretion of fasudil hydrochloride, a RHO kinase inhibitor, in rats and dogs. Biopharmaceutics & Drug Disposition. 41(4-5). 206–220. 6 indexed citations
7.
Lu, Jiangjie, Yong Zeng, Xiulin Yi, et al.. (2020). Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection. BMC Complementary Medicine and Therapies. 20(1). 334–334. 1 indexed citations
8.
Wang, Ze, Yazhuo Li, Chen Zhang, et al.. (2020). Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescription. Acta Pharmaceutica Sinica B. 10(9). 1646–1657. 15 indexed citations
9.
Li, Yazhuo, Wei Li, Wei Zhou, et al.. (2020). Pharmacokinetics, tissue distribution and excretion of a novel long-acting human insulin analogue – recombinant insulin LysArg in rats. Xenobiotica. 51(3). 307–315. 1 indexed citations
10.
He, Yufei, Ying Xie, Xiulin Yi, et al.. (2019). Potential synergic mechanism of Wutou-Gancao herb-pair by inhibiting efflux transporter P-glycoprotein. Journal of Pharmaceutical Analysis. 10(2). 178–186. 25 indexed citations
11.
He, Yufei, et al.. (2019). Effects of liquorice on pharmacokinetics of aconitine in rats. Xenobiotica. 49(12). 1485–1493. 9 indexed citations
12.
He, Yufei, et al.. (2018). Potential detoxification effect of active ingredients in liquorice by upregulating efflux transporter. Phytomedicine. 56. 175–182. 23 indexed citations
13.
Wang, Ze, Cui Tao, Yinghui Sun, et al.. (2018). The effect of polymorphism of uric acid transporters on uric acid transport. Journal of Nephrology. 32(2). 177–187. 69 indexed citations
14.
Li, Ying, Xuemin Zheng, Xiulin Yi, et al.. (2017). Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist. The FASEB Journal. 31(6). 2603–2611. 64 indexed citations
15.
Huang, Changjiang, Xiulin Yi, Dexin Kong, Ligong Chen, & Min Gong. (2016). Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide. Oncotarget. 7(32). 52230–52238. 8 indexed citations
16.
Yi, Xiulin, Lixin Jiang, Jing Gao, et al.. (2015). The Targeted-liposome Delivery System of Antitumor Drugs. Current Drug Metabolism. 16(10). 894–910. 14 indexed citations
17.
Liu, Changxiao, Xiulin Yi, Huirong Fan, et al.. (2015). Effects of Drug Transporters on Pharmacological Responses and Safety. Current Drug Metabolism. 16(9). 732–752. 7 indexed citations
18.
Si, Duanyun, et al.. (2014). Inhibitory effect of medicinal plant-derived carboxylic acids on the human transporters hOAT1, hOAT3, hOATP1B1, and hOATP2B1. Chinese Journal of Natural Medicines. 12(2). 131–138. 2 indexed citations
19.
Liu, Changxiao, et al.. (2011). Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters. Current Drug Metabolism. 12(9). 835–849. 47 indexed citations
20.
Yi, Xiulin. (2010). Pharmacokinetics evaluation on applications of human drug transporter. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026